000			01262 a2200349 4500
005			20250513171520.0
264		0	_c20000131
008			200001s 0 0 eng d
022			_a1075-2765
040			_aNLM _beng _cNLM
100	1		_aVelasco, M
245	0	0	_aDopamine: pharmacologic and therapeutic aspects. _h[electronic resource]
260			_bAmerican journal of therapeutics _cJan 1998
300			_a37-43 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aBrain Ischemia _xdrug therapy
650	0	4	_aCardiovascular System _xdrug effects
650	0	4	_aCentral Nervous System _xdrug effects
650	0	4	_aDopamine _xpharmacology
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDopamine Antagonists _xpharmacology
650	0	4	_aEpilepsy _xdrug therapy
650	0	4	_aGastrointestinal Motility _xdrug effects
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aKidney _xdrug effects
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aPsychotic Disorders _xdrug therapy
650	0	4	_aReceptors, Dopamine _xdrug effects
700	1		_aLuchsinger, A
773	0		_tAmerican journal of therapeutics _gvol. 5 _gno. 1 _gp. 37-43
999			_c10058667 _d10058667